Artificial Intelligence–based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing?
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Fibroblast growth factor receptor (FGFR) inhibitor treatment has become the first clinically approved targeted therapy in bladder cancer. However, it requires previous molecular testing of each patient, which is costly and not ubiquitously available. OBJECTIVE: To determine whether an artificial intelligence system is able to predict mutations of the FGFR3 gene directly from routine histology slides of bladder cancer. DESIGN, SETTING, AND PARTICIPANTS: We trained a deep learning network to detect FGFR3 mutations on digitized slides of muscle-invasive bladder cancers stained with hematoxylin and eosin from the Cancer Genome Atlas (TCGA) cohort (n = 327) and validated the algorithm on the "Aachen" cohort (n = 182; n = 121 pT2-4, n = 34 stroma-invasive pT1, and n = 27 noninvasive pTa tumors). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary endpoint was the area under the receiver operating curve (AUROC) for mutation detection. Performance of the deep learning system was compared with visual scoring by an uropathologist. RESULTS AND LIMITATIONS: In the TCGA cohort, FGFR3 mutations were detected with an AUROC of 0.701 (p < 0.0001). In the Aachen cohort, FGFR3 mutants were found with an AUROC of 0.725 (p < 0.0001). When trained on TCGA, the network generalized to the Aachen cohort, and detected FGFR3 mutants with an AUROC of 0.625 (p = 0.0112). A subgroup analysis and histological evaluation found highest accuracy in papillary growth, luminal gene expression subtypes, females, and American Joint Committee on Cancer (AJCC) stage II tumors. In a head-to-head comparison, the deep learning system outperformed the uropathologist in detecting FGFR3 mutants. CONCLUSIONS: Our computer-based artificial intelligence system was able to detect genetic alterations of the FGFR3 gene of bladder cancer patients directly from histological slides. In the future, this system could be used to preselect patients for further molecular testing. However, analyses of larger, multicenter, muscle-invasive bladder cancer cohorts are now needed in order to validate and extend our findings. PATIENT SUMMARY: In this report, a computer-based artificial intelligence (AI) system was applied to histological slides to predict genetic alterations of the FGFR3 gene in bladder cancer. We found that the AI system was able to find the alteration with high accuracy. In the future, this system could be used to preselect patients for further molecular testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kather, J. N., Pearson, A. T., Halama, N., Jäger, D., Krause, J., Loosen, S. H., Marx, A., Boor, P., Tacke, F., Neumann, U. P., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0462-y · Cited by 1,458
Self-citationDeep learning in cancer pathology: a new generation of clinical biomarkers
Echle, A., Rindtorff, N. T., Brinker, T. J., Luedde, T., Pearson, A. T., & Kather, J. N. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01122-x · Cited by 667 · cited 1×
“Until a few years ago, computer-based analysis of digitized histological slides was confined to simple tasks such as tumor detection [4], but recently deep learning has enabled significant progress in this field [5].”
BackgroundSelf-citationMulti-class texture analysis in colorectal cancer histology
Kather, J. N., Weis, C.-A., Bianconi, F., Melchers, S. M., Schad, L. R., Gaiser, T., Marx, A., & Zöllner, F. G. (2016) · Scientific Reports · doi:10.1038/srep27988 · Cited by 578 · cited 1×
“Until a few years ago, computer-based analysis of digitized histological slides was confined to simple tasks such as tumor detection [4], but recently deep learning has enabled significant progress in this field [5].”
BackgroundSelf-citationClinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning
Echle, A., Grabsch, H. I., Quirke, P., van den Brandt, P. A., West, N. P., Hutchins, G. G. A., Heij, L. R., Tan, X., Richman, S. D., Krause, J., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.021 · Cited by 376
Self-citationAl‐Ahmadie, H. A., Iyer, G., Janakiraman, M., Lin, O., Heguy, A., Tickoo, S. K., Fine, S. W., Gopalan, A., Chen, Y., Balar, A., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2892 · Cited by 88 · cited 3×
“Other features stated by Al-Ahmadie et al [11] were less efficient, and both the pathologist and the AI-based algorithm failed several times.”
BackgroundMethodInfluential
Cited by
Artificial intelligence for multimodal data integration in oncology
Lipkova, J., Chen, R. J., Chen, B., Lu, M. Y., Barbieri, M., Shao, D., Vaidya, A. J., Chen, C., Zhuang, L., Williamson, D. F. K., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.09.012 · Cited by 777
Artificial intelligence in histopathology: enhancing cancer research and clinical oncology
Shmatko, A., Ghaffari Laleh, N., Gerstung, M., & Kather, J. N. (2022) · Nature Cancer · doi:10.1038/s43018-022-00436-4 · Cited by 446
“Although this predicted intratumor heterogeneity could be seen as a mere artifact of complex processing pipelines, it has been shown to reflect genetic heterogeneity 79,83,84 as well as spatial patterns of 19 and Kather et al. 20 . transcriptomically defined cell types 19,79 .”
BackgroundSelf-citationArtificial intelligence for digital and computational pathology
Song, A. H., Jaume, G., Williamson, D. F. K., Lu, M. Y., Vaidya, A., Miller, T. R., & Mahmood, F. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00096-8 · Cited by 356
Swarm learning for decentralized artificial intelligence in cancer histopathology
Saldanha, O. L., Quirke, P., West, N. P., James, J. A., Loughrey, M. B., Grabsch, H. I., Salto-Tellez, M., Alwers, E., Cifci, D., Ghaffari Laleh, N., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01768-5 · Cited by 227
Self-citationBenchmarking artificial intelligence methods for end-to-end computational pathology
Laleh, N. G., Muti, H. S., Lavinia Loeffler, C. M., Echle, A., Saldanha, O. L., Mahmood, F., Lu, M. Y., Trautwein, C., Langer, R., Dislich, B., et al. (2021) · doi:10.1101/2021.08.09.455633 · Cited by 13
“[2,5,17,18,20] We demonstrate that morphological subtyping of renal cell carcinoma (RCC) is an easy task which can be solved by any common computational pathology method with high performance (Table 1 and Table 2), without significant differences between methods (Suppl.”
MethodSelf-citation
Metadata
- Authors
- Loeffler, C. M. L., Ortiz Bruechle, N., Jung, M., Seillier, L., Rose, M., Laleh, N. G., Knuechel, R., Brinker, T. J., Trautwein, C., Gaisa, N. T., & Kather, J. N.
- Venue
- European Urology Focus
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 8
- Issue
- 2
- Pages
- 472-479
- ISSN
- 2405-4569 (ISSN-L)
- OpenAlex
- W3158883948
- Cited by
- 85
- References
- 5
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Artificial Intelligence–based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing? https://app.cochat.ai/papers/10.1016/j.euf.2021.04.007
- The paper
- Loeffler, C. M. L., Ortiz Bruechle, N., Jung, M., Seillier, L., Rose, M., Laleh, N. G., Knuechel, R., Brinker, T. J., Trautwein, C., Gaisa, N. T., & Kather, J. N. (2022). Artificial Intelligence–based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing? European Urology Focus. https://doi.org/10.1016/j.euf.2021.04.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.